Skip to main content
OpenTrials
Completed

NCT Number: NCT01055730

The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease

The purpose of this study is to determine if pulmonary rehabilitation has any effect on breathlessness, quality of life, physical function and depression in persons with interstitial lung disease.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Interstitial Lung Disease Behavior Dyspnea Fibrosis Lung Diseases Lung Diseases, Interstitial Mobility Limitation Pathologic Processes Pathological Conditions, Signs and Symptoms Personal Satisfaction Psychological Well-Being Pulmonary Fibrosis Respiration Disorders Respiratory Tract Diseases Signs and Symptoms Signs and Symptoms, Respiratory

Age range

19 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University of British Columbia, Vancouver, British Columbia, Canada

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults (> 18 years old) with a diagnosis of ILD who are referred to a participating PR program

Exclusion criteria

  • Inability to provide informed consent
  • Inability to read and write English
  • Any other medical condition that significantly limits the subject's ability to perform the functional measures
  • Emphysema / Chronic bronchitis (FEV1 / FVC ratio < 60%)
  • Previous pulmonary rehabilitation

Treatment and study plan

Pulmonary Rehabilitation

Other

Structured education and supervised exercise program, lasting between 6 and 9 weeks.

Primary outcomes

  1. 6-minute walk distance

    Time frame: Immediately following completion of pulmonary rehabilitation and 6 months following the start of pulmonary rehabilitation

  2. Quality of life

    Time frame: Immediately following completion of pulmonary rehabilitation and 6 months following the start of pulmonary rehabilitation

Secondary outcomes

  1. Dyspnea

    Time frame: Immediately following completion of pulmonary rehabilitation and 6 months following the start of pulmonary rehabilitation

  2. Depression

    Time frame: Immediately following completion of pulmonary rehabilitation and 6 months following the start of pulmonary rehabilitation

Sponsors and collaborators

Lead sponsor

University of California, San Francisco

Other

Registry information

Official study title

The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease: A Prospective Cohort Study

Acronym: PR-ILD

Important dates

Study start
2010
Primary completion
2013
Study completion
2013
First posted
Jan 26, 2010
Registry last updated
Nov 21, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.